The digital genome market is set to observe exponential growth on account of rising prevalence of severe chronic and genetic disorders around the world.
The digital genome market is set to observe exponential growth on account of rising prevalence of severe chronic and genetic disorders around the world. Patients nowadays are preferring digitalized genomic solutions over traditional treatment solutions due to their precise diagnostic capabilities. Generally, lack of physical activity, consumption of harmful substances and unhealthy lifestyles are claimed to be some of the major cases of chronic diseases.
Technological developments in the field of biotechnology and genomics could drive the emergence of new rapid DNA sequencing solutions at affordable price points, influencing digital genome business outlook over the forthcoming years. According to Global Market Insights, Inc., the digital genome market might reach USD 50.4 billion by the year 2025.
Proliferating demand for customized medicines for clinical diagnosis could hugely boost the adoption of digital genome solutions. Moreover, various federal organizations like the European Commission, Genome Canada and the National Institute of Health are investing immense efforts in streamlining the volunteering process for research genomics-based clinical trials. These developments could play a crucial role in enhancing new treatments & tests for chronic diseases.
Mentioned below are some of the factors strengthening digital genome market share:
Escalating demand from the livestock & agriculture sectors -
Genetic testing technologies are gaining immense popularity across the agriculture and livestock sector. Diagnosis like bovine genetic tests are finding immense application in the livestock sector for testing animals including cattle, dairy cows, and beef.
Farming animals that possess certain traits like faster weight gain, high yield of milk, efficient nutrient utilization, disease resistance and tenderness of meat are considered to be economically useful for food production.
Meanwhile, the dairy industry is also employing genetic testing technologies to enhance the production of dairy products. Animals that do not have any disease are capable of generating good quality food and consume nutrients in an efficient manner.
To access sample pages of this report titled, “Digital Genome Market Size By Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Preparation Instruments), By Application (Microbiology {Biological, Clinical, Industrial}, Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), By End-Use (Diagnostics & Forensic Labs, Academic Research Institutes, Hospitals, Bio-Pharmaceutical Companies) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/1219
Emergence of advanced gene-editing techniques -
With the advent of advanced gene-editing techniques, the field of genomics is anticipated to witness the advent of new treatment procedure for rare and infectious diseases. Next generation sequencing, computer aided, bio-python drug delivery system, which is mainly used by physicians, are massively benefiting the adoption of digital genome solutions.
Hospitals are employing DNA sequencing for diagnosing organ for rejection prior to transplanting. Rapid applications of genomics in drug development, diagnosis, preventing adverse drug reactions and transplanting in hospitals could positively impact the digital genome market size.
Adoption of modern business strategies -
Global Digital Genome Market players are Dickson and Company, Becton, PerkinElmer Inc. and F. Hoffmann-La Roche Ltd. The industry players are focusing on developing effective analysis and sequencing instruments to enhance their product portfolio. Companies are adopting innovative research projects for creating new-age technologies like next-generation sequencing and chain terminator DNA sequencing.
In 2020, Concepta Diagnostics signed an acquisition deal with home-administered postal genomic test service provider the Genome Store for £0.28 million, with and aim to broaden its product portfolio. Meanwhile, Resolve Biosciences, a leading developer of Molecular Cartography™, revealed that it has raised almost $24 million from its Series A financing round.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com